抗高血压药物研究现状及新进展  

Present situation and research progress of dyazide

作　　者：刘海洲[1] 肖强[1] 王志萍[1] 张媛媛[1] 

机构地区：[1]青岛科技大学化工学院,山东青岛266042

出　　处：《化工科技市场》2008年第6期31-33,72,共4页Chemical Technology Market

基　　金：国家自然科学基金资助课题(批准号:20772070)

摘　　要：心血管疾病是威胁人类健康的头号杀手,而高血压是其中最为多见的疾病之一。近年来,高血压已经成为危害人类健康的主要杀手,引起了抗高血压药物市场的快速发展。有关资料显示,到2009年,全球降压药市场将超过580亿美元,预计年增长率将保持在7%左右。Angiocardiopathy is the number-one killer of treatening people＇s heahh, and hypertension is one of the most common disease. In recent years,hypertension has become the major threaten to people＇s health, which causes the dyazide market develop rapidly. Relevant data showed that the global hypotensive drug market will exceed 58 000 million dollar by 2009 ,and the annual incremental rate will maintain about 7%.

关 键 词：高血压 心血管 血管紧张素 受体 

分 类 号：R972.4[医药卫生—药品]